Entera Bio Reports Second Quarter 2019 Financial Results and Provides Operating Update
August 20, 2019 07:00 ET
|
Entera Bio Ltd.
Phase 2 study for oral PTH in osteoporosis was initiated in June 2019; Data expected in 2020Completed Part 2 of a Phase 2 PK/PD study in hypoparathyroidism patients. Results expected to be presented...